SixPeaks Bio AG Therapeutics
Latest round
- Series A
Last raised
- May 2024
Total raised
- $30M
Investors
- 2
About SixPeaks Bio AG Therapeutics
Based in Basel, Switzerland, and founded in 2022, SixPeaks Bio AG Therapeutics operates as a biopharmaceutical company developing therapeutic dietary drugs. The company develops therapies and medicines for healthy weight loss and metabolic fitness. SixPeaks Bio targets muscle preservation while promoting weight loss, addressing a critical gap in obesity treatments. The pipeline of therapies offered by the company includes a dual-specific antibody targeting activin type IIA and B receptors. This antibody aims to preserve skeletal muscle mass while facilitating weight loss, enhancing the efficacy and long-term utility of GLP-1-based therapies, which traditionally result in significant muscle loss.
Who invested in SixPeaks Bio AG Therapeutics
2 investors across 1 round
See all investors in SixPeaks Bio AG Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 22, 2024
Amount
$30M
Investors
Questions about SixPeaks Bio AG Therapeutics
Who invested in SixPeaks Bio AG Therapeutics?
SixPeaks Bio AG Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SixPeaks Bio AG Therapeutics raised?
SixPeaks Bio AG Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SixPeaks Bio AG Therapeutics last raise money?
SixPeaks Bio AG Therapeutics's most recent round on record is a Series A, in May 2024.
What does SixPeaks Bio AG Therapeutics do?
Based in Basel, Switzerland, and founded in 2022, SixPeaks Bio AG Therapeutics operates as a biopharmaceutical company developing therapeutic dietary drugs.
Where is SixPeaks Bio AG Therapeutics headquartered?
SixPeaks Bio AG Therapeutics is headquartered in Basel, Switzerland.
Which VCs invest in companies like SixPeaks Bio AG Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at SixPeaks Bio AG Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SixPeaks Bio AG Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.